Human Gene MIR136 (ENST00000385207.2) from GENCODE V44
  Description: Homo sapiens microRNA 136 (MIR136), microRNA. (from RefSeq NR_029699)
RefSeq Summary (NR_029699): microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]. Sequence Note: This record represents a predicted microRNA stem-loop as defined by miRBase. Some sequence at the 5' and 3' ends may not be included in the intermediate precursor miRNA produced by Drosha cleavage.
Gencode Transcript: ENST00000385207.2
Gencode Gene: ENSG00000207942.2
Transcript (Including UTRs)
   Position: hg38 chr14:100,884,702-100,884,783 Size: 82 Total Exon Count: 1 Strand: +


Page IndexSequence and LinksPrimersCTDRNA-Seq ExpressionMicroarray Expression
Other SpeciesmRNA DescriptionsOther NamesMethods
Data last updated at UCSC: 2023-08-18 00:09:47

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr14:100,884,702-100,884,783)mRNA (may differ from genome)No protein
Gene SorterGenome BrowserOther Species FASTATable SchemaBioGPSEnsembl
Entrez GeneExonPrimerGencodeHGNCLynxMalacards
OMIMPubMedBioGrid CRISPR DB

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 0.00 RPKM in Adipose - Subcutaneous
Total median expression: 0.00 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
      
      
      
      
      

-  Descriptions from all associated GenBank mRNAs
  LF205127 - JP 2014500723-A/12630: Polycomb-Associated Non-Coding RNAs.
MA440704 - JP 2018138019-A/12630: Polycomb-Associated Non-Coding RNAs.
LF209650 - JP 2014500723-A/17153: Polycomb-Associated Non-Coding RNAs.
MA445227 - JP 2018138019-A/17153: Polycomb-Associated Non-Coding RNAs.
CS266409 - Sequence 101 from Patent WO2005118806.
DL076571 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004221 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FU261185 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763687 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV525907 - Nucleic acid controling mast cell degranulation.
FW421563 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HV304586 - JP 2009531018-A/153: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305084 - JP 2009531019-A/153: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV491966 - WO 2011087154-A/139: Method For Screening Induced Pluripotent Stem Cells.
HW119293 - JP 2013046612-A/153: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW262170 - JP 2013516982-A/139: Method For Screening Induced Pluripotent Stem Cells.
HW367434 - JP 2012228254-A/101: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411827 - JP 2014000079-A/101: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW589622 - JP 2013121348-A/153: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW674173 - JP 2014217381-A/101: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ067115 - JP 2014012020-A/101: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ408280 - JP 2015528002-A/877: CHIRAL CONTROL.
HZ413426 - JP 2014060993-A/153: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ427539 - JP 2014217384-A/101: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428342 - JP 2014217385-A/101: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429145 - JP 2014217386-A/101: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429948 - JP 2014217387-A/101: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ501637 - JP 2016025853-A/153: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ769205 - JP 2014223080-A/101: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058599 - Sequence 101 from Patent EP2298893.
JA059402 - Sequence 101 from Patent EP2298894.
JA073725 - Sequence 101 from Patent EP2281887.
JA104862 - Sequence 101 from Patent EP2302051.
JA106202 - Sequence 101 from Patent EP2302052.
JA107005 - Sequence 101 from Patent EP2302053.
JA107808 - Sequence 101 from Patent EP2302054.
JA108611 - Sequence 101 from Patent EP2302055.
JA109414 - Sequence 101 from Patent EP2302056.
JA191930 - Sequence 101 from Patent EP2290066.
JA192829 - Sequence 101 from Patent EP2290067.
JA193728 - Sequence 101 from Patent EP2290068.
JA194627 - Sequence 101 from Patent EP2290069.
JA195526 - Sequence 101 from Patent EP2290070.
JA196425 - Sequence 101 from Patent EP2290071.
JA197324 - Sequence 101 from Patent EP2290072.
JA198223 - Sequence 101 from Patent EP2290073.
JA199122 - Sequence 101 from Patent EP2290074.
JA200021 - Sequence 101 from Patent EP2290075.
JA200920 - Sequence 101 from Patent EP2290076.
JA218042 - Sequence 101 from Patent EP2281888.
JA226193 - Sequence 101 from Patent EP2292755.
JA229048 - Sequence 101 from Patent EP2292756.
JA257319 - Sequence 101 from Patent EP2284265.
JA278599 - Sequence 101 from Patent EP2281886.
JA284485 - Sequence 101 from Patent EP2281889.
JA292538 - Sequence 101 from Patent EP2287303.
JA317724 - Sequence 101 from Patent EP2314688.
JA374783 - Sequence 101 from Patent EP2322616.
JA526003 - Sequence 153 from Patent EP2369011.
JA526510 - Sequence 153 from Patent EP2369012.
JA527017 - Sequence 153 from Patent EP2369013.
JA535946 - Sequence 153 from Patent EP2371971.
JA787951 - Sequence 153 from Patent EP2479285.
JA788449 - Sequence 153 from Patent EP2479286.
JA810783 - Sequence 153 from Patent EP2468890.
JA811281 - Sequence 153 from Patent EP2468891.
JA811779 - Sequence 153 from Patent EP2468893.
JA812277 - Sequence 153 from Patent EP2468894.
JA812775 - Sequence 153 from Patent EP2468895.
JA813273 - Sequence 153 from Patent EP2468896.
JA813771 - Sequence 153 from Patent EP2468897.
JA814269 - Sequence 153 from Patent EP2468898.
JA814767 - Sequence 153 from Patent EP2468899.
JA817010 - Sequence 153 from Patent EP2468892.
JA825822 - Sequence 153 from Patent EP2471956.
JA826320 - Sequence 153 from Patent EP2471958.
JB024607 - Sequence 153 from Patent EP2505668.
JB025105 - Sequence 153 from Patent EP2505669.
JB079492 - Sequence 153 from Patent EP2487252.
JB079990 - Sequence 153 from Patent EP2487253.
JB080488 - Sequence 153 from Patent EP2487254.
JB080986 - Sequence 153 from Patent EP2487255.
JB081484 - Sequence 153 from Patent EP2487256.
JB081982 - Sequence 153 from Patent EP2487257.
JB082480 - Sequence 153 from Patent EP2487258.
JB082978 - Sequence 153 from Patent EP2487259.
JB083476 - Sequence 153 from Patent EP2487260.
JB083974 - Sequence 153 from Patent EP2487261.
JB084472 - Sequence 153 from Patent EP2487262.
JB084970 - Sequence 153 from Patent EP2487263.
JB087648 - Sequence 153 from Patent EP2502630.
JB147852 - Sequence 153 from Patent EP2484782.
JB148350 - Sequence 153 from Patent EP2484783.
JB153075 - Sequence 153 from Patent EP2514433.
JB153573 - Sequence 153 from Patent EP2514434.
JB622162 - Sequence 153 from Patent EP2586454.
JB622660 - Sequence 153 from Patent EP2586455.
JC001723 - Sequence 153 from Patent EP2591794.
JC208077 - Sequence 139 from Patent EP2524033.
JC221626 - Sequence 101 from Patent EP2471923.
JC268192 - Sequence 101 from Patent EP2471924.
JC340500 - Sequence 101 from Patent EP2471922.
JC469746 - Sequence 101 from Patent EP2471921.
JC990535 - Sequence 101 from Patent EP2808390.
LF714638 - JP 2016165292-A/101: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856572 - JP 2015142597-A/101: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
LG051614 - KR 1020150036642-A/880: CHIRAL CONTROL.
LZ215732 - JP 2017518753-A/83: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS.
MP065920 - Sequence 34 from Patent WO2018228875.
CS266599 - Sequence 291 from Patent WO2005118806.
DL076761 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004411 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FU261186 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763688 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FW421753 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HV304587 - JP 2009531018-A/154: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305085 - JP 2009531019-A/154: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW119294 - JP 2013046612-A/154: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW367624 - JP 2012228254-A/291: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW412017 - JP 2014000079-A/291: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW589623 - JP 2013121348-A/154: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW674363 - JP 2014217381-A/291: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ067305 - JP 2014012020-A/291: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ413427 - JP 2014060993-A/154: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ427729 - JP 2014217384-A/291: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428532 - JP 2014217385-A/291: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429335 - JP 2014217386-A/291: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ430138 - JP 2014217387-A/291: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ501638 - JP 2016025853-A/154: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ769395 - JP 2014223080-A/291: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058789 - Sequence 291 from Patent EP2298893.
JA059592 - Sequence 291 from Patent EP2298894.
JA073915 - Sequence 291 from Patent EP2281887.
JA105052 - Sequence 291 from Patent EP2302051.
JA106392 - Sequence 291 from Patent EP2302052.
JA107195 - Sequence 291 from Patent EP2302053.
JA107998 - Sequence 291 from Patent EP2302054.
JA108801 - Sequence 291 from Patent EP2302055.
JA109604 - Sequence 291 from Patent EP2302056.
JA192120 - Sequence 291 from Patent EP2290066.
JA193019 - Sequence 291 from Patent EP2290067.
JA193918 - Sequence 291 from Patent EP2290068.
JA194817 - Sequence 291 from Patent EP2290069.
JA195716 - Sequence 291 from Patent EP2290070.
JA196615 - Sequence 291 from Patent EP2290071.
JA197514 - Sequence 291 from Patent EP2290072.
JA198413 - Sequence 291 from Patent EP2290073.
JA199312 - Sequence 291 from Patent EP2290074.
JA200211 - Sequence 291 from Patent EP2290075.
JA201110 - Sequence 291 from Patent EP2290076.
JA218232 - Sequence 291 from Patent EP2281888.
JA226383 - Sequence 291 from Patent EP2292755.
JA229238 - Sequence 291 from Patent EP2292756.
JA257509 - Sequence 291 from Patent EP2284265.
JA278789 - Sequence 291 from Patent EP2281886.
JA284675 - Sequence 291 from Patent EP2281889.
JA292728 - Sequence 291 from Patent EP2287303.
JA317914 - Sequence 291 from Patent EP2314688.
JA374973 - Sequence 291 from Patent EP2322616.
JA526004 - Sequence 154 from Patent EP2369011.
JA526511 - Sequence 154 from Patent EP2369012.
JA527018 - Sequence 154 from Patent EP2369013.
JA535947 - Sequence 154 from Patent EP2371971.
JA787952 - Sequence 154 from Patent EP2479285.
JA788450 - Sequence 154 from Patent EP2479286.
JA810784 - Sequence 154 from Patent EP2468890.
JA811282 - Sequence 154 from Patent EP2468891.
JA811780 - Sequence 154 from Patent EP2468893.
JA812278 - Sequence 154 from Patent EP2468894.
JA812776 - Sequence 154 from Patent EP2468895.
JA813274 - Sequence 154 from Patent EP2468896.
JA813772 - Sequence 154 from Patent EP2468897.
JA814270 - Sequence 154 from Patent EP2468898.
JA814768 - Sequence 154 from Patent EP2468899.
JA817011 - Sequence 154 from Patent EP2468892.
JA825823 - Sequence 154 from Patent EP2471956.
JA826321 - Sequence 154 from Patent EP2471958.
JB024608 - Sequence 154 from Patent EP2505668.
JB025106 - Sequence 154 from Patent EP2505669.
JB079493 - Sequence 154 from Patent EP2487252.
JB079991 - Sequence 154 from Patent EP2487253.
JB080489 - Sequence 154 from Patent EP2487254.
JB080987 - Sequence 154 from Patent EP2487255.
JB081485 - Sequence 154 from Patent EP2487256.
JB081983 - Sequence 154 from Patent EP2487257.
JB082481 - Sequence 154 from Patent EP2487258.
JB082979 - Sequence 154 from Patent EP2487259.
JB083477 - Sequence 154 from Patent EP2487260.
JB083975 - Sequence 154 from Patent EP2487261.
JB084473 - Sequence 154 from Patent EP2487262.
JB084971 - Sequence 154 from Patent EP2487263.
JB087649 - Sequence 154 from Patent EP2502630.
JB147853 - Sequence 154 from Patent EP2484782.
JB148351 - Sequence 154 from Patent EP2484783.
JB153076 - Sequence 154 from Patent EP2514433.
JB153574 - Sequence 154 from Patent EP2514434.
JB622163 - Sequence 154 from Patent EP2586454.
JB622661 - Sequence 154 from Patent EP2586455.
JC001724 - Sequence 154 from Patent EP2591794.
JC221816 - Sequence 291 from Patent EP2471923.
JC268382 - Sequence 291 from Patent EP2471924.
JC340690 - Sequence 291 from Patent EP2471922.
JC469936 - Sequence 291 from Patent EP2471921.
JC990725 - Sequence 291 from Patent EP2808390.
LF714828 - JP 2016165292-A/291: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856762 - JP 2015142597-A/291: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
CQ873655 - Sequence 74 from Patent WO2004076622.
CS548275 - Sequence 1305 from Patent EP1777301.
DD413492 - Regulation of Mammalian Cells.
DJ003759 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
DJ027038 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
DJ087829 - Novel miRNA molecules isolated from human embryonic stem cell.
FU261423 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763925 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV524351 - Nucleic acid controling mast cell degranulation.
FW312015 - DETECTING NUCLEIC ACIDS.
FW364004 - Oligonucleotides for modulating target RNA activity.
HI416812 - Sequence 24 from Patent EP2136846.
HI965446 - Sequence 731 from Patent WO2010139812.
HI965773 - Sequence 93 from Patent WO2010139811.
HI966639 - Sequence 93 from Patent WO2010139810.
HV304824 - JP 2009531018-A/391: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305322 - JP 2009531019-A/391: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV492022 - WO 2011087154-A/195: Method For Screening Induced Pluripotent Stem Cells.
HV594887 - JP 2010539959-A/268: Micromirs.
HV938814 - JP 2011519579-A/1642: Oligonucleotides Containing Arabinose Modified Nucleotides For Treating Inflammation and Neoplastic Cell Proliferation.
HV954046 - JP 2012518421-A/958: METHODS OF DETECTING LUNG CANCER.
HW119531 - JP 2013046612-A/391: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW262226 - JP 2013516982-A/195: Method For Screening Induced Pluripotent Stem Cells.
HW289792 - JP 2013520158-A/35: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION.
HW589860 - JP 2013121348-A/391: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW608531 - JP 2014515024-A/20: Micro-RNA Inhibitors and Their Uses in Disease.
HW669299 - JP 2013537538-A/30: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
HZ074121 - JP 2013535982-A/212: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ082915 - JP 2015513906-A/272: Stem Cell Microparticles.
HZ157444 - JP 2015130862-A/268: Micromirs.
HZ186317 - JP 2015146814-A/66: Oligonucleotides for modulating target RNA activity.
HZ392529 - JP 2015180203-A/35: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION.
HZ413664 - JP 2014060993-A/391: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ436696 - JP 2015529450-A/272: Stem Cell Microparticles.
HZ479793 - JP 2015535430-A/299: TERMINALLY MODIFIED RNA.
HZ501875 - JP 2016025853-A/391: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ789724 - JP 2016504050-A/1469: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA401484 - Sequence 731 from Patent WO2011080318.
JA402462 - Sequence 731 from Patent WO2011080315.
JA403469 - Sequence 731 from Patent WO2011080316.
JA406100 - Sequence 731 from Patent EP2336353.
JA429626 - Sequence 731 from Patent WO2011095623.
JA526241 - Sequence 391 from Patent EP2369011.
JA526748 - Sequence 391 from Patent EP2369012.
JA527255 - Sequence 391 from Patent EP2369013.
JA536184 - Sequence 391 from Patent EP2371971.
JA715176 - Sequence 958 from Patent EP2401406.
JA788189 - Sequence 391 from Patent EP2479285.
JA788687 - Sequence 391 from Patent EP2479286.
JA811021 - Sequence 391 from Patent EP2468890.
JA811519 - Sequence 391 from Patent EP2468891.
JA812017 - Sequence 391 from Patent EP2468893.
JA812515 - Sequence 391 from Patent EP2468894.
JA813013 - Sequence 391 from Patent EP2468895.
JA813511 - Sequence 391 from Patent EP2468896.
JA814009 - Sequence 391 from Patent EP2468897.
JA814507 - Sequence 391 from Patent EP2468898.
JA815005 - Sequence 391 from Patent EP2468899.
JA817248 - Sequence 391 from Patent EP2468892.
JA821121 - Sequence 1642 from Patent EP2285961.
JA826060 - Sequence 391 from Patent EP2471956.
JA826558 - Sequence 391 from Patent EP2471958.
JB024845 - Sequence 391 from Patent EP2505668.
JB025343 - Sequence 391 from Patent EP2505669.
JB050174 - Sequence 261 from Patent WO2013020926.
JB079730 - Sequence 391 from Patent EP2487252.
JB080228 - Sequence 391 from Patent EP2487253.
JB080726 - Sequence 391 from Patent EP2487254.
JB081224 - Sequence 391 from Patent EP2487255.
JB081722 - Sequence 391 from Patent EP2487256.
JB082220 - Sequence 391 from Patent EP2487257.
JB082718 - Sequence 391 from Patent EP2487258.
JB083216 - Sequence 391 from Patent EP2487259.
JB083714 - Sequence 391 from Patent EP2487260.
JB084212 - Sequence 391 from Patent EP2487261.
JB084710 - Sequence 391 from Patent EP2487262.
JB085208 - Sequence 391 from Patent EP2487263.
JB087886 - Sequence 391 from Patent EP2502630.
JB148090 - Sequence 391 from Patent EP2484782.
JB148588 - Sequence 391 from Patent EP2484783.
JB153313 - Sequence 391 from Patent EP2514433.
JB153811 - Sequence 391 from Patent EP2514434.
JB158032 - Sequence 20 from Patent WO2012142313.
JB175225 - Sequence 257 from Patent WO2012101219.
JB620297 - Sequence 277 from Patent WO2013063544.
JB622400 - Sequence 391 from Patent EP2586454.
JB622898 - Sequence 391 from Patent EP2586455.
JB835765 - Sequence 55 from Patent WO2013057567.
JC001961 - Sequence 391 from Patent EP2591794.
JC171900 - Sequence 272 from Patent WO2013150303.
JC208133 - Sequence 195 from Patent EP2524033.
JC269639 - Sequence 30 from Patent WO2012020307.
JC334117 - Sequence 35 from Patent EP2487240.
JC512456 - Sequence 2709 from Patent WO2014113089.
JC572711 - Sequence 272 from Patent WO2014125276.
JC582399 - Sequence 272 from Patent WO2014125277.
JE954095 - Sequence 272 from Patent WO2015052526.
JE955848 - Sequence 272 from Patent WO2015052527.
LF137600 - JP 2016507550-A/272: Method of Producing Microparticles.
LF160853 - JP 2016513950-A/919: Oligomers with improved off-target profile.
LF162565 - JP 2016513095-A/272: Stem Cell Microparticles and miRNA.
LF953317 - JP 2016534103-A/272: Stem Cell Microparticles and miRNA.
LG005662 - KR 1020150004822-A/272: STEM CELL MICROPARTICLES.
LG053358 - KR 1020150059168-A/272: STEM CELL MICROPARTICLES.
LG240597 - KR 1020160035087-A/272: STEM CELL MICROPARTICLES AND MIRNA.
LP726399 - Sequence 93 from Patent EP2883966.
LP769610 - Sequence 137 from Patent EP3294910.
LP818669 - Sequence 93 from Patent EP3296406.
LP938611 - Sequence 93 from Patent EP3184651.
LP951827 - Sequence 333 from Patent WO2017157650.
LQ070044 - Sequence 368 from Patent EP2964234.
LQ278468 - Sequence 7 from Patent WO2016066288.
LQ420444 - Sequence 20 from Patent WO2016127998.
LV470682 - JP 2016534036-A/272: Stem Cell Microparticles and miRNA.
LX270096 - JP 2016056210-A/30: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
LY404952 - KR 1020160117535-A/257: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY504775 - KR 1020170035932-A/164: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
LZ233674 - JP 2017184756-A/66: Oligonucleotides for modulating target RNA activity.
LZ243056 - JP 2017525350-A/164: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
MA260191 - JP 2017505623-A/257: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA400950 - JP 2018515097-A/137: Method for Diagnosis and Prognosis of Chronic Heart Failure.
MA643545 - JP 2017113010-A/1469: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA730243 - JP 2017125065-A/30: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
MA731429 - JP 2017140048-A/299: TERMINALLY MODIFIED RNA.
MA783860 - WO 2018181877-A/1: Anti-cancer agent using miRNA.
MP065921 - Sequence 35 from Patent WO2018228875.
MP070538 - Sequence 135 from Patent WO2018231851.
MS834585 - Sequence 731 from Patent EP3112479.
MS944908 - Sequence 164 from Patent EP3177739.
MA403155 - JP 2018131391-A/2: MicroRNA formation inhibitor and method for producing the same.
AY882312 - Homo sapiens microRNA HSA-MIR-RG-81, complete sequence.
FW364005 - Oligonucleotides for modulating target RNA activity.
HI965445 - Sequence 730 from Patent WO2010139812.
HI966178 - Sequence 498 from Patent WO2010139811.
HI967044 - Sequence 498 from Patent WO2010139810.
HV492023 - WO 2011087154-A/196: Method For Screening Induced Pluripotent Stem Cells.
HV594888 - JP 2010539959-A/269: Micromirs.
HV938815 - JP 2011519579-A/1643: Oligonucleotides Containing Arabinose Modified Nucleotides For Treating Inflammation and Neoplastic Cell Proliferation.
HW262227 - JP 2013516982-A/196: Method For Screening Induced Pluripotent Stem Cells.
HW669300 - JP 2013537538-A/31: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
HW913354 - JP 2015504307-A/114: METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS.
HZ074122 - JP 2013535982-A/213: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ082725 - JP 2015513906-A/82: Stem Cell Microparticles.
HZ157445 - JP 2015130862-A/269: Micromirs.
HZ186318 - JP 2015146814-A/67: Oligonucleotides for modulating target RNA activity.
HZ436506 - JP 2015529450-A/82: Stem Cell Microparticles.
HZ479792 - JP 2015535430-A/298: TERMINALLY MODIFIED RNA.
HZ789723 - JP 2016504050-A/1468: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA401483 - Sequence 730 from Patent WO2011080318.
JA402461 - Sequence 730 from Patent WO2011080315.
JA403468 - Sequence 730 from Patent WO2011080316.
JA406099 - Sequence 730 from Patent EP2336353.
JA429625 - Sequence 730 from Patent WO2011095623.
JA660584 - Sequence 38 from Patent WO2011131354.
JA757959 - Sequence 92 from Patent WO2012010584.
JA808552 - Sequence 24 from Patent WO2012083969.
JA821122 - Sequence 1643 from Patent EP2285961.
JB022640 - Sequence 482 from Patent WO2013026685.
JB620298 - Sequence 278 from Patent WO2013063544.
JB778735 - Sequence 114 from Patent WO2013078283.
JC171710 - Sequence 82 from Patent WO2013150303.
JC208134 - Sequence 196 from Patent EP2524033.
JC269640 - Sequence 31 from Patent WO2012020307.
JC512455 - Sequence 2708 from Patent WO2014113089.
JC572521 - Sequence 82 from Patent WO2014125276.
JC582209 - Sequence 82 from Patent WO2014125277.
JE953905 - Sequence 82 from Patent WO2015052526.
JE955658 - Sequence 82 from Patent WO2015052527.
JE978593 - Sequence 38 from Patent EP2865765.
LF137410 - JP 2016507550-A/82: Method of Producing Microparticles.
LF160226 - JP 2016513950-A/292: Oligomers with improved off-target profile.
LF162375 - JP 2016513095-A/82: Stem Cell Microparticles and miRNA.
LF953127 - JP 2016534103-A/82: Stem Cell Microparticles and miRNA.
LG005472 - KR 1020150004822-A/82: STEM CELL MICROPARTICLES.
LG053168 - KR 1020150059168-A/82: STEM CELL MICROPARTICLES.
LG240407 - KR 1020160035087-A/82: STEM CELL MICROPARTICLES AND MIRNA.
LP726804 - Sequence 498 from Patent EP2883966.
LP819074 - Sequence 498 from Patent EP3296406.
LP939016 - Sequence 498 from Patent EP3184651.
LQ070043 - Sequence 367 from Patent EP2964234.
LQ724524 - Sequence 157 from Patent WO2018096084.
LV470492 - JP 2016534036-A/82: Stem Cell Microparticles and miRNA.
LX270097 - JP 2016056210-A/31: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
LY404953 - KR 1020160117535-A/258: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY504658 - KR 1020170035932-A/47: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
LZ215685 - JP 2017518753-A/36: COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE FRACTURES AND DISORDERS.
LZ233675 - JP 2017184756-A/67: Oligonucleotides for modulating target RNA activity.
LZ242939 - JP 2017525350-A/47: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
MA260192 - JP 2017505623-A/258: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA643544 - JP 2017113010-A/1468: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA730244 - JP 2017125065-A/31: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
MA731428 - JP 2017140048-A/298: TERMINALLY MODIFIED RNA.
MP065889 - Sequence 3 from Patent WO2018228875.
MS637915 - Sequence 32 from Patent WO2017037190.
MS834584 - Sequence 730 from Patent EP3112479.
MS902009 - Sequence 482 from Patent EP3156505.
MS944791 - Sequence 47 from Patent EP3177739.
MA800598 - JP 2018183181-A/1469: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA800597 - JP 2018183181-A/1468: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MP129372 - Sequence 272 from Patent EP3470073.
MP162295 - Sequence 272 from Patent WO2019069093.
MP129182 - Sequence 82 from Patent EP3470073.
MP162105 - Sequence 82 from Patent WO2019069093.
MB018391 - JP 2018504915-A/20: A microRNA-based method for early detection of prostate cancer in urine samples.
MP280686 - Sequence 106 from Patent WO2019111197.
MP272086 - Sequence 34 from Patent WO2019157381.
MP283599 - Sequence 106 from Patent WO2019111198.
MB453613 - JP 2018509178-A/179: Methods for Highly Parallel and Accurate Measurement of Nucleic Acids.

-  Other Names for This Gene
  Alternate Gene Symbols: ENST00000385207.1, NR_029699, uc010txk.1, uc010txk.2, uc010txk.3
UCSC ID: ENST00000385207.2
RefSeq Accession: NR_029699

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.